ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
Open accessThe DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Abstract
The rise of antibiotic resistance and a dwindling antimicrobial pipeline have been recognized as emerging threats to public health. The ESKAPE pathogens — Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter spp. — were initially identified as critical multidrug-resistant bacteria for which effective therapies were rapidly needed. Now, entering the third decade of the twenty-first century, and despite the introduction of several new antibiotics and antibiotic adjuvants, such as novel β-lactamase inhibitors, these organisms continue to represent major therapeutic challenges. These bacteria share several key biological features, including adaptations for survival in the modern health-care setting, diverse methods for acquiring resistance determinants and the dissemination of successful high-risk clones around the world. With the advent of next-generation sequencing, novel tools to track and combat the spread of these organisms have rapidly evolved, as well as renewed interest in non-traditional antibiotic approaches. In this Review, we explore the current epidemiology and clinical impact of this important group of bacterial pathogens and discuss relevant mechanisms of resistance to recently introduced antibiotics that affect their use in clinical settings. Furthermore, we discuss emerging therapeutic strategies needed for effective patient care in the era of widespread antimicrobial resistance. In this Review, Miller and Arias summarize recent advances in understanding ESKAPE pathogens, focusing on their molecular epidemiology, clinical impact, emerging mechanisms of resistance and novel therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973
Acinetobacter baumannii : Emergence of a Successful Pathogen
Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00058-07 · Cited by 3,316
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Podschun, R., & Ullmann, U. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.589 · Cited by 2,688
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Antibacterial drug discovery in the resistance era
Brown, E. D., & Wright, G. D. (2016) · Nature · doi:10.1038/nature17042 · Cited by 2,247
Antimicrobial Resistance in ESKAPE Pathogens
De Oliveira, D. M. P., Forde, B. M., Kidd, T. J., Harris, P. N. A., Schembri, M. A., Beatson, S. A., Paterson, D. L., & Walker, M. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00181-19 · Cited by 2,078
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,908
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628
Logan, L. K., & Weinstein, R. A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw282 · Cited by 1,584
Sulakvelidze, A., Alavidze, Z., & Morris, J. G. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.649-659.2001 · Cited by 1,566
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412
Holt, K. E., Wertheim, H., Zadoks, R. N., Baker, S., Whitehouse, C. A., Dance, D., Jenney, A., Connor, T. R., Hsu, L. Y., Severin, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501049112 · Cited by 1,236
Population genomics of Klebsiella pneumoniae
Wyres, K. L., Lam, M. M. C., & Holt, K. E. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0315-1 · Cited by 1,160
Maragakis, L. L., & Perl, T. M. (2008) · Clinical Infectious Diseases · doi:10.1086/529198 · Cited by 969
Ito, T., Katayama, Y., Asada, K., Mori, N., Tsutsumimoto, K., Tiensasitorn, C., & Hiramatsu, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1323-1336.2001 · Cited by 963
Antimicrobial Resistance in Escherichia coli
Poirel, L., Madec, J.-Y., Lupo, A., Schink, A.-K., Kieffer, N., Nordmann, P., & Schwarz, S. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0026-2017 · Cited by 876
Global antibiotic consumption and usage in humans, 2000–18: a spatial modelling study
Browne, A. J., Chipeta, M. G., Haines-Woodhouse, G., Kumaran, E. P. A., Hamadani, B. H. K., Zaraa, S., Henry, N. J., Deshpande, A., Reiner, R. C., Day, N. P. J., et al. (2021) · The Lancet Planetary Health · doi:10.1016/s2542-5196(21)00280-1 · Cited by 865
Bassetti, M., Echols, R., Matsunaga, Y., Ariyasu, M., Doi, Y., Ferrer, R., Lodise, T. P., Naas, T., Niki, Y., Paterson, D. L., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30796-9 · Cited by 828
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
David, S., Reuter, S., Harris, S. R., Glasner, C., Feltwell, T., Argimon, S., Abudahab, K., Goater, R., Giani, T., Errico, G., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0492-8 · Cited by 773
Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa
Bonomo, R. A., & Szabo, D. (2006) · Clinical Infectious Diseases · doi:10.1086/504477 · Cited by 741
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740 · cited 1×
“…(for which sulbactam is the active component against A. baumannii PBP3) is the current preferred backbone of therapy, with evidence of improved outcomes when used at a high dose (≥9 g per day of sulbactam) in combination with another active agent in mostly observational studies 180 .”
Diancourt, L., Passet, V., Nemec, A., Dijkshoorn, L., & Brisse, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010034 · Cited by 719
Weiner-Lastinger, L. M., Abner, S., Edwards, J. R., Kallen, A. J., Karlsson, M., Magill, S. S., Pollock, D., See, I., Soe, M. M., Walters, M. S., et al. (2020) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2019.296 · Cited by 707
Rodríguez-Baño, J., Gutiérrez-Gutiérrez, B., Machuca, I., & Pascual, A. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00079-17 · Cited by 704
Potron, A., Poirel, L., & Nordmann, P. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.03.001 · Cited by 688
Bartual, S. G., Seifert, H., Hippler, C., Luzon, M. A. D., Wisplinghoff, H., & Rodríguez-Valera, F. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4382-4390.2005 · Cited by 662
Methicillin-Resistant Staphylococcus aureus in U.S. Hospitals, 1975–1991
Panlilio, A. L., Culver, D. H., Gaynes, R. P., Banerjee, S., Henderson, T. S., Tolson, J. S., Martone, W. J., & System, N. N. I. S. (1992) · Infection Control & Hospital Epidemiology · doi:10.1086/646432 · Cited by 657
van Duin, D., Lok, J. J., Earley, M., Cober, E., Richter, S. S., Perez, F., Salata, R. A., Kalayjian, R. C., Watkins, R. R., Doi, Y., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix783 · Cited by 655
The increasing threat of Pseudomonas aeruginosa high-risk clones
Oliver, A., Mulet, X., López-Causapé, C., & Juan, C. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.08.002 · Cited by 644
Kadri, S. S., Adjemian, J., Lai, Y. L., Spaulding, A. B., Ricotta, E., Prevots, D. R., Palmore, T. N., Rhee, C., Klompas, M., Dekker, J. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy378 · Cited by 605
Gutiérrez-Gutiérrez, B., Salamanca, E., de Cueto, M., Hsueh, P.-R., Viale, P., Paño-Pardo, J. R., Venditti, M., Tumbarello, M., Daikos, G., Cantón, R., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30228-1 · Cited by 512
The role of vaccines in combatting antimicrobial resistance
Micoli, F., Bagnoli, F., Rappuoli, R., & Serruto, D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00506-3 · Cited by 500
Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages
Zarrilli, R., Pournaras, S., Giannouli, M., & Tsakris, A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.09.008 · Cited by 496
Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii
Hamidian, M., & Nigro, S. J. (2019) · Microbial Genomics · doi:10.1099/mgen.0.000306 · Cited by 465
Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal Strains
Lebreton, F., van Schaik, W., Manson McGuire, A., Godfrey, P., Griggs, A., Mazumdar, V., Corander, J., Cheng, L., Saif, S., Young, S., et al. (2013) · mBio · doi:10.1128/mbio.00534-13 · Cited by 455
Examining horizontal gene transfer in microbial communities
Brito, I. L. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00534-7 · Cited by 442
Phylogenomics and systematics in Pseudomonas
Gomila, M., Peña, A., Mulet, M., Lalucat, J., & GarcÃa-Valdés, E. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00214 · Cited by 433
Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe
Otter, J. A., & French, G. L. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70053-0 · Cited by 398
Considerations for the Use of Phage Therapy in Clinical Practice
Suh, G. A., Lodise, T. P., Tamma, P. D., Knisely, J. M., Alexander, J., Aslam, S., Barton, K. D., Bizzell, E., Totten, K. M. C., Campbell, J. L., et al. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02071-21 · Cited by 378
Genetic Basis for In Vivo Daptomycin Resistance in Enterococci
Arias, C. A., Panesso, D., McGrath, D. M., Qin, X., Mojica, M. F., Miller, C., Diaz, L., Tran, T. T., Rincon, S., Barbu, E. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011138 · Cited by 377 · cited 2×
“Daptomycin resistance generally arises through activation of the LiaFSR cell envelope stress response system in conjunction with changes in cell membrane phospholipid metabolism 53 (Fig.”
Self-citationdel Barrio-Tofiño, E., López-Causapé, C., & Oliver, A. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106196 · Cited by 372
Emerging Antimicrobial-Resistant High-Risk Klebsiella pneumoniae Clones ST307 and ST147
Peirano, G., Chen, L., Kreiswirth, B. N., & Pitout, J. D. D. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01148-20 · Cited by 363
Wang, M., Earley, M., Chen, L., Hanson, B. M., Yu, Y., Liu, Z., Salcedo, S., Cober, E., Li, L., Kanj, S. S., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00399-6 · Cited by 363
Self-citationUdo, E. (1993) · Journal of Hospital Infection · doi:10.1016/0195-6701(93)90100-e · Cited by 357
Zhanel, G. G., Chung, P., Adam, H., Zelenitsky, S., Denisuik, A., Schweizer, F., Lagacé-Wiens, P. R. S., Rubinstein, E., Gin, A. S., Walkty, A., et al. (2014) · Drugs · doi:10.1007/s40265-013-0168-2 · Cited by 340
Multidrug-Resistant Enterobacter cloacae Complex Emerging as a Global, Diversifying Threat
Annavajhala, M. K., Gomez-Simmonds, A., & Uhlemann, A.-C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00044 · Cited by 340
van Duin, D., Arias, C. A., Komarow, L., Chen, L., Hanson, B. M., Weston, G., Cober, E., Garner, O. B., Jacob, J. T., Satlin, M. J., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30755-8 · Cited by 337
Self-citationShariati, A., Dadashi, M., Moghadam, M. T., van Belkum, A., Yaslianifard, S., & Darban-Sarokhalil, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-69058-z · Cited by 329
Population structure of Pseudomonas aeruginosa
Wiehlmann, L., Wagner, G., Cramer, N., Siebert, B., Gudowius, P., Morales, G., Köhler, T., van Delden, C., Weinel, C., Slickers, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609213104 · Cited by 327
Crisóstomo, M. I., Westh, H., Tomasz, A., Chung, M., Oliveira, D. C., & de Lencastre, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161272898 · Cited by 322
Reyes, J., Komarow, L., Chen, L., Ge, L., Hanson, B. M., Cober, E., Herc, E., Alenazi, T., Kaye, K. S., Garcia-Diaz, J., et al. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00329-9 · Cited by 321
Self-citationTreatment and Prevention of Urinary Tract Infection with Orally Active FimH Inhibitors
Cusumano, C. K., Pinkner, J. S., Han, Z., Greene, S. E., Ford, B. A., Crowley, J. R., Henderson, J. P., Janetka, J. W., & Hultgren, S. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003021 · Cited by 318
Kaye, K. S., Shorr, A. F., Wunderink, R. G., Du, B., Poirier, G. E., Rana, K., Miller, A., Lewis, D., O'Donnell, J., Chen, L., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00184-6 · Cited by 315
Marshall, S., Hujer, A. M., Rojas, L. J., Papp-Wallace, K. M., Humphries, R. M., Spellberg, B., Hujer, K. M., Marshall, E. K., Rudin, S. D., Perez, F., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02243-16 · Cited by 293
Raad, I., Darouiche, R., Vazquez, J., Lentnek, A., Hachem, R., Hanna, H., Goldstein, B., Henkel, T., & Seltzer, E. (2005) · Clinical Infectious Diseases · doi:10.1086/427283 · Cited by 292
Freschi, L., Vincent, A. T., Jeukens, J., Emond-Rheault, J.-G., Kukavica-Ibrulj, I., Dupont, M.-J., Charette, S. J., Boyle, B., & Levesque, R. C. (2019) · Genome Biology and Evolution · doi:10.1093/gbe/evy259 · Cited by 286
Durand-Réville, T. F., Guler, S., Comita-Prevoir, J., Chen, B., Bifulco, N., Huynh, H., Lahiri, S., Shapiro, A. B., McLeod, S. M., Carter, N. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.104 · Cited by 285
Karakonstantis, S., Rousaki, M., & Kritsotakis, E. I. (2022) · Antibiotics · doi:10.3390/antibiotics11060723 · Cited by 284
Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus
Nübel, U., Roumagnac, P., Feldkamp, M., Song, J.-H., Ko, K. S., Huang, Y.-C., Coombs, G., Ip, M., Westh, H., Skov, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804178105 · Cited by 274
Berrazeg, M., Jeannot, K., Ntsogo Enguéné, V. Y., Broutin, I., Loeffert, S., Fournier, D., & Plésiat, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00825-15 · Cited by 268
Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii
Héritier, C., Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01320.x · Cited by 266
Gene Dosage and Linezolid Resistance in Enterococcus faecium and Enterococcus faecalis
Marshall, S. H., Donskey, C. J., Hutton-Thomas, R., Salata, R. A., & Rice, L. B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3334-3336.2002 · Cited by 263
Penwell, W. F., Shapiro, A. B., Giacobbe, R. A., Gu, R.-F., Gao, N., Thresher, J., McLaughlin, R. E., Huband, M. D., DeJonge, B. L. M., Ehmann, D. E., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04808-14 · Cited by 251
Hanssen, A.-M., Kjeldsen, G., & Sollid, J. U. E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.285-296.2004 · Cited by 248
Gales, A. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg416 · Cited by 242
Antibiotics in the clinical pipeline as of December 2022
Butler, M. S., Henderson, I. R., Capon, R. J., & Blaskovich, M. A. T. (2023) · The Journal of Antibiotics · doi:10.1038/s41429-023-00629-8 · Cited by 239
Zhang, Y., Jin, L., Ouyang, P., Wang, Q., Wang, R., Wang, J., Gao, H., Wang, X., Wang, H., China Carbapenem-Resistant Enterobacteriaceae (CRE) Network, et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz446 · Cited by 231
Grein, F., Müller, A., Scherer, K. M., Liu, X., Ludwig, K. C., Klöckner, A., Strach, M., Sahl, H.-G., Kubitscheck, U., & Schneider, T. (2020) · Nature Communications · doi:10.1038/s41467-020-15257-1 · Cited by 230
Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci
Miller, W. R., Bayer, A. S., & Arias, C. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026997 · Cited by 227
Self-citationFalcone, M., Bassetti, M., Tiseo, G., Giordano, C., Nencini, E., Russo, A., Graziano, E., Tagliaferri, E., Leonildi, A., Barnini, S., et al. (2020) · Critical Care · doi:10.1186/s13054-020-2742-9 · Cited by 225
Hamrick, J. C., Docquier, J.-D., Uehara, T., Myers, C. L., Six, D. A., Chatwin, C. L., John, K. J., Vernacchio, S. F., Cusick, S. M., Trout, R. E. L., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01963-19 · Cited by 224
Diekema, D. J., Pfaller, M. A., Shortridge, D., Zervos, M., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy270 · Cited by 221
Gales, A. C., Seifert, H., Gur, D., Castanheira, M., Jones, R. N., & Sader, H. S. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy293 · Cited by 220
Pena, C., Cabot, G., Gomez-Zorrilla, S., Zamorano, L., Ocampo-Sosa, A., Murillas, J., Almirante, B., Pomar, V., Aguilar, M., Granados, A., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu866 · Cited by 216
Global emergence of the widespread Pseudomonas aeruginosa ST235 clone
Treepong, P., Kos, V. N., Guyeux, C., Blanc, D. S., Bertrand, X., Valot, B., & Hocquet, D. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.06.018 · Cited by 212
Bowers, J. R., Kitchel, B., Driebe, E. M., MacCannell, D. R., Roe, C., Lemmer, D., de Man, T., Rasheed, J. K., Engelthaler, D. M., Keim, P., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0133727 · Cited by 209
Epidemic Klebsiella pneumoniae ST258 Is a Hybrid Strain
Chen, L., Mathema, B., Pitout, J. D. D., DeLeo, F. R., & Kreiswirth, B. N. (2014) · mBio · doi:10.1128/mbio.01355-14 · Cited by 209
Long, S. W., Linson, S. E., Ojeda Saavedra, M., Cantu, C., Davis, J. J., Brettin, T., & Olsen, R. J. (2017) · mSphere · doi:10.1128/mspheredirect.00290-17 · Cited by 209
Hackel, M. A., Tsuji, M., Yamano, Y., Echols, R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00093-17 · Cited by 202
Liao, W., Liu, Y., & Zhang, W. (2020) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2020.09.004 · Cited by 201
Geriak, M., Haddad, F., Rizvi, K., Rose, W., Kullar, R., LaPlante, K., Yu, M., Vasina, L., Ouellette, K., Zervos, M., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02483-18 · Cited by 195
Haidar, G., Clancy, C. J., Shields, R. K., Hao, B., Cheng, S., & Nguyen, M. H. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02534-16 · Cited by 193
Frost, I., Sati, H., Garcia-Vello, P., Hasso-Agopsowicz, M., Lienhardt, C., Gigante, V., & Beyer, P. (2023) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00303-2 · Cited by 193
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria
Schwarz, S., Zhang, W., Du, X.-D., Krüger, H., Feßler, A. T., Ma, S., Zhu, Y., Wu, C., Shen, J., & Wang, Y. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00188-20 · Cited by 189
Chavda, K. D., Chen, L., Fouts, D. E., Sutton, G., Brinkac, L., Jenkins, S. G., Bonomo, R. A., Adams, M. D., & Kreiswirth, B. N. (2016) · mBio · doi:10.1128/mbio.02093-16 · Cited by 187
Integrons: Vehicles and pathways for horizontal dissemination in bacteria
Domingues, S., da Silva, G. J., & Nielsen, K. M. (2012) · Mobile Genetic Elements · doi:10.4161/mge.22967 · Cited by 176
Resistance in Vancomycin-Resistant Enterococci
Miller, W. R., Murray, B. E., Rice, L. B., & Arias, C. A. (2020) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2020.08.004 · Cited by 173
Self-citationFalcone, M., Tiseo, G., Carbonara, S., Marino, A., Di Caprio, G., Carretta, A., Mularoni, A., Mariani, M. F., Maraolo, A. E., Scotto, R., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad100 · Cited by 173
Holt, K., Kenyon, J. J., Hamidian, M., Schultz, M. B., Pickard, D. J., Dougan, G., & Hall, R. (2016) · Microbial Genomics · doi:10.1099/mgen.0.000052 · Cited by 172
Origin, evolution, and global transmission of community-acquired Staphylococcus aureus ST8
Strauß, L., Stegger, M., Akpaka, P. E., Alabi, A. S., Breurec, S., Coombs, G. W., Egyir, B., Larsen, A. R., Laurent, F. J., Monecke, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702472114 · Cited by 172
Host and Pathogen Biomarkers for Severe Pseudomonas aeruginosa Infections
Juan, C., Peña, C., & Oliver, A. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw299 · Cited by 170
Castanheira, M., Deshpande, L. M., Mendes, R. E., Canton, R., Sader, H. S., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy347 · Cited by 169
Sun, D., Rubio-Aparicio, D., Nelson, K., Dudley, M. N., & Lomovskaya, O. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01694-17 · Cited by 166
Comparative Analysis of the Two Acinetobacter baumannii Multilocus Sequence Typing (MLST) Schemes
Gaiarsa, S., Batisti Biffignandi, G., Esposito, E. P., Castelli, M., Jolley, K. A., Brisse, S., Sassera, D., & Zarrilli, R. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00930 · Cited by 163
Coombs, G. W., Nimmo, G. R., Bell, J. M., Huygens, F., O'Brien, F. G., Malkowski, M. J., Pearson, J. C., Stephens, A. J., & Giffard, P. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.10.4735-4743.2004 · Cited by 161
Long, S. W., Olsen, R. J., Eagar, T. N., Beres, S. B., Zhao, P., Davis, J. J., Brettin, T. S., Xia, F., & Musser, J. M. (2017) · mBio · doi:10.1128/mbio.00489-17 · Cited by 161
Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review
Palacios-Baena, Z. R., Giannella, M., Manissero, D., Rodríguez-Baño, J., Viale, P., Lopes, S., Wilson, K., McCool, R., & Longshaw, C. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.10.016 · Cited by 161
Genomic Epidemiology of Global Carbapenemase-Producing Enterobacter spp., 2008–2014
Peirano, G., Matsumura, Y., Adams, M. D., Bradford, P., Motyl, M., Chen, L., Kreiswirth, B. N., & Pitout, J. D. D. (2018) · Emerging Infectious Diseases · doi:10.3201/eid2406.171648 · Cited by 159
Shields, R. K., Paterson, D. L., & Tamma, P. D. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad094 · Cited by 159
Plasmids Shaped the Recent Emergence of the Major Nosocomial Pathogen Enterococcus faecium
Arredondo-Alonso, S., Top, J., McNally, A., Puranen, S., Pesonen, M., Pensar, J., Marttinen, P., Braat, J. C., Rogers, M. R. C., van Schaik, W., et al. (2020) · mBio · doi:10.1128/mbio.03284-19 · Cited by 153
Genomic Diversity within the Enterobacter cloacae Complex
Paauw, A., Caspers, M. P. M., Schuren, F. H. J., Hall, M. A. L., Delétoile, A., Montijn, R. C., Verhoef, J., & Fluit, A. C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003018 · Cited by 151
Lee, H.-Y., Chen, C., Wu, S.-R., Huang, C.-W., & Chiu, C. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000125 · Cited by 151
Galloway-Peña, J., Roh, J. H., Latorre, M., Qin, X., & Murray, B. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030187 · Cited by 148
Becker, K., Ballhausen, B., Köck, R., & Kriegeskorte, A. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2014.06.007 · Cited by 146
Fiedler, S., Bender, J. K., Klare, I., Halbedel, S., Grohmann, E., Szewzyk, U., & Werner, G. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv420 · Cited by 146
Moyá, B., Barceló, I. M., Bhagwat, S., Patel, M. V., Bou, G., Papp‐Wallace, K. M., Bonomo, R. A., & Oliver, A. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02529-16 · Cited by 145
Shortridge, D., Gales, A. C., Streit, J. M., Huband, M. D., Tsakris, A., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy343 · Cited by 144
Malik, S., Kaminski, M. A., Landman, D., & Quale, J. M. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01221-20 · Cited by 142
Zilberberg, M. D., Nathanson, B. H., Sulham, K., Fan, W., & Shorr, A. F. (2016) · Critical Care · doi:10.1186/s13054-016-1392-4 · Cited by 140
Planet, P. J., Díaz, L., Kolokotronis, S., Narechania, A., Reyes, J., Xing, G., Rincón, S., Smith, H., Panesso, D., Ryan, C., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv320 · Cited by 139
Self-citationCyclic Boronates Inhibit All Classes of β-Lactamases
Cahill, S. T., Cain, R. M., Wang, D. Y., Lohans, C. T., Wareham, D. W., Oswin, H. P., Mohammed, J., Spencer, J., Fishwick, C. W. G., McDonough, M. A., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02260-16 · Cited by 135
Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis
Fowler, V. G., Das, A., Lipka, J., Schuch, R., Pomerantz, R. J., Jáuregui-Peredo, L., Bressler, A. M., Evans, D. C., Moran, G. J., Rupp, M. E., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136577 · Cited by 134
Poirel, L., Sadek, M., & Nordmann, P. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00877-21 · Cited by 133
Young, K., Painter, R. E., Raghoobar, S. L., Hairston, N. N., Racine, F., Wisniewski, D., Balibar, C. J., Villafania, A., Zhang, R., Sahm, D. F., et al. (2019) · BMC Microbiology · doi:10.1186/s12866-019-1522-7 · Cited by 132
Ozer, E. A., Nnah, E., Didelot, X., Whitaker, R. J., & Hauser, A. R. (2019) · Genome Biology and Evolution · doi:10.1093/gbe/evz119 · Cited by 128
Molecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States
Adams‐Haduch, J. M., Onuoha, E. O., Bogdanovich, T., Tian, G., Marschall, J., Urban, C. M., Spellberg, B. J., Rhee, D., Halstead, D. C., Pasculle, A. W., et al. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00619-11 · Cited by 127
Pfaller, M. A., Cormican, M., Flamm, R. K., Mendes, R. E., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy344 · Cited by 126
Kaul, M., Mark, L., Zhang, Y., Parhi, A. K., Lyu, Y. L., Pawlak, J., Saravolatz, S. N., Saravolatz, L. D., Weinstein, M. P., LaVoie, E. J., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00708-15 · Cited by 124
Origin and Evolution of European Community-Acquired Methicillin-Resistant Staphylococcus aureus
Stegger, M., Wirth, T., Andersen, P. S., Skov, R. L., Grassi, A., Martins-Simões, P., Tristan, A., Petersen, A., Aziz, M., Kiil, K., et al. (2014) · mBio · doi:10.1128/mbio.01044-14 · Cited by 124
Tindall, B. J., Sutton, G., & Garrity, G. M. (2016) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.001572 · Cited by 124
Turton, J. F., Payne, Z., Coward, A., Hopkins, K. L., Turton, J. A., Doumith, M., & Woodford, N. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000653 · Cited by 124
Gomez‐Simmonds, A., Annavajhala, M. K., Wang, Z., Maćešić, N., Hu, Y., Giddins, M. J., O’Malley, A., Toussaint, N. C., Whittier, S., Torres, V. J., et al. (2018) · mBio · doi:10.1128/mbio.00542-18 · Cited by 124
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia
Holland, T. L., Cosgrove, S. E., Doernberg, S. B., Jenkins, T. C., Turner, N., Boucher, H. W., Pavlov, O., Titov, I., Kosulnykov, S., Atanasov, B. T., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2300220 · Cited by 123
Wagenlehner, F., Perry, C., Hooton, T. M., Scangarella-Oman, N. E., Millns, H., Powell, M., Jarvis, E., Dennison, J., Sheets, A., Butler, D. A., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02196-7 · Cited by 123
Eravacycline: A Review in Complicated Intra-Abdominal Infections
Scott, L. J. (2019) · Drugs · doi:10.1007/s40265-019-01067-3 · Cited by 120
Clinical outcomes of type III Pseudomonas aeruginosa bacteremia*
El-Solh, A., Hattemer, A., Hauser, A. R., Alhajhusain, A., & Vora, H. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182377906 · Cited by 119
Liu, C., Chen, K., Wu, Y., Huang, L., Fang, Y., Lu, J., Zeng, Y., Xie, M., Chan, E. W., Chen, S., et al. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2093134 · Cited by 119
Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020
Prasad, N. K., Seiple, I. B., Cirz, R. T., & Rosenberg, O. S. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00054-22 · Cited by 118
Olivier, C., Blake, R. K., Steed, L. L., & Salgado, C. D. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/587647 · Cited by 116
Raven, K. E., Reuter, S., Reynolds, R., Brodrick, H. J., Russell, J. E., Török, M. E., Parkhill, J., & Peacock, S. J. (2016) · Genome Research · doi:10.1101/gr.204024.116 · Cited by 114
Britt, N. S., Potter, E. M., Patel, N., & Steed, M. E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw815 · Cited by 113
Roe, C. C., Vazquez, A. J., Esposito, E. P., Zarrilli, R., & Sahl, J. W. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00542 · Cited by 109
Klebsiella pneumoniae ST307 with bla OXA-181, South Africa, 2014–2016
Lowe, M., Kock, M. M., Coetzee, J., Hoosien, E., Peirano, G., Strydom, K., Ehlers, M. M., Mbelle, N. M., Shashkina, E., Haslam, D. B., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2504.181482 · Cited by 108
Song, Y., Liu, C.-I., Lin, F., No, J. H., Hensler, M. E., Liu, Y.-L., Jeng, W. Y., Low, J., Liu, G. Y., Nizet, V., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9001764 · Cited by 106
Chen, Z., Erickson, D. L., & Meng, J. (2020) · BMC Genomics · doi:10.1186/s12864-020-07041-8 · Cited by 105
Iovleva, A., Mustapha, M. M., Griffith, M. P., Komarow, L., Luterbach, C., Evans, D. R., Cober, E., Richter, S. S., Rydell, K., Arias, C. A., et al. (2022) · mBio · doi:10.1128/mbio.02759-21 · Cited by 104
Self-citationEichel, V. M., Last, K., Brühwasser, C., von Baum, H., Dettenkofer, M., Götting, T., Grundmann, H., Güldenhöven, H., Liese, J., Martin, M., et al. (2023) · Journal of Hospital Infection · doi:10.1016/j.jhin.2023.09.008 · Cited by 101
Probing the Mobilome: Discoveries in the Dynamic Microbiome
Carr, V. R., Shkoporov, A. N., Hill, C., Mullany, P. P., & Moyes, D. L. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.05.003 · Cited by 99
Gill, C. M., Aktaþ, E., Alfouzan, W. A., Bourassa, L. A., Brink, A. J., Burnham, C. D., Cantón, R., Carmeli, Y., Falcone, M., Kiffer, C. R. V., et al. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04308-0 · Cited by 99
Billal, D. S., Feng, J., Leprohon, P., Légaré, D., & Ouellette, M. (2011) · BMC Genomics · doi:10.1186/1471-2164-12-512 · Cited by 98
Klein, E. Y., Jiang, W., Mojica, N., Tseng, K. K., McNeill, R., Cosgrove, S. E., & Perl, T. M. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy399 · Cited by 98
Karlsson, M., Stanton, R. A., Ansari, U. A., McAllister, G. A., Chan, M., Sula, E., Grass, J. E., Duffy, N., Anacker, M. L., Witwer, M. L., et al. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00519-19 · Cited by 93
Ito, T., Katayama, Y., Asada, K., Mori, N., Tsutsumimoto, K., Tiensasitorn, C., & Hiramatsu, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3677-3677.2001 · Cited by 93
Cyclic Boronates Inhibit All Classes of β-Lactamase
Cahill, S. T., Cain, R. M., Wang, D. Y., Lohans, C. T., Wareham, D. W., Oswin, H. P., Mohammed, J., SPENCER, J. M., Fishwick, C. W. G., McDonough, M. A., et al. (2017) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 91
Kawai, A., McElheny, C. L., Iovleva, A., Kline, E. G., Sluis‐Cremer, N., Shields, R. K., & Doi, Y. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00198-20 · Cited by 87
Uhlemann, A., McAdam, P. R., Sullivan, S. B., Knox, J., Khiabanian, H., Rabadán, R., Davies, P. R., Fitzgerald, J. R., & Lowy, F. D. (2017) · mBio · doi:10.1128/mbio.01375-16 · Cited by 85
Lan, P., Lu, Y., Chen, Z., Wu, X., Hua, X., Jiang, Y., Zhou, J., & Yu, Y. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00084-22 · Cited by 85
Kramer, T. S., Remschmidt, C., Werner, S., Behnke, M., Schwab, F., Werner, G., Gastmeier, P., & Leistner, R. (2018) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-018-0419-9 · Cited by 82
The global dissemination of hospital clones of Enterococcus faecium
Enterococcal Group, van Hal, S. J., Willems, R. J. L., Gouliouris, T., Ballard, S. A., Coque, T. M., Hammerum, A. M., Hegstad, K., Westh, H. T., Howden, B. P., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00868-0 · Cited by 79
Streling, A. P., Al‐Obaidi, M. M., Lainhart, W., Zangeneh, T. T., Khan, A., Dinh, A. Q., Hanson, B., Arias, C. A., & Miller, W. R. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1909 · Cited by 78
Self-citationBæk, K. T., Thøgersen, L., Mogensen, R. G., Mellergaard, M., Thomsen, L. E., Petersen, A., Skov, S., Cameron, D. R., Peleg, A. Y., & Frees, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01303-15 · Cited by 77
Wilson, B. M., Chakhtoura, N. G. E., Patel, S. R., Saade, E., Donskey, C. J., Bonomo, R. A., & Pérez, F. (2017) · Emerging infectious diseases · doi:10.3201/eid2305.162034 · Cited by 73
He, L., Zheng, H., Wang, Y., LE, K. Y., Liu, Q., Shang, J., Dai, Y., Meng, H., Wang, X., Li, T., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0514-9 · Cited by 73
Berti, A. D., Theisen, E., Sauer, J., Nonejuie, P., Olson, J., Pogliano, J., Sakoulas, G., Nizet, V., Proctor, R. A., & Rose, W. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02071-15 · Cited by 68
Satlin, M. J., Nicolau, D. P., Humphries, R. M., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz845 · Cited by 67
Rubio, A. M., Kline, E. G., Jones, C. E., Chen, L., Kreiswirth, B. N., Nguyen, M. H., Clancy, C. J., Cooper, V. S., Haidar, G., Tyne, D. V., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00084-21 · Cited by 67
Thrane, S. W., Taylor, V. L., Freschi, L., Kukavica‐Ibrulj, I., Boyle, B., Laroche, J., Pirnay, J., Lévesque, R. C., Lam, J. S., & Jelsbak, L. (2015) · mBio · doi:10.1128/mbio.01396-15 · Cited by 66
Ríos, R., Reyes, J., Carvajal, L. P., Rincón, S., Panesso, D., Echeverri, A. M., Dinh, A. Q., Kolokotronis, S., Narechania, A., Tran, T. T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62371-7 · Cited by 66
Self-citationKumburu, H. H., Sonda, T., van Zwetselaar, M., Leekitcharoenphon, P., Lukjančenko, O., Mmbaga, B. T., Alifrangis, M., Lund, O., Aarestrup, F. M., & Kibiki, G. S. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz055 · Cited by 64
GERMS-SA, F., Perovic, O., Ismail, H., Quan, V., Bamford, C., Nana, T., Chibabhai, V., Bhola, P., Ramjathan, P., Swe-Han, K. S., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03845-4 · Cited by 64
Wittke, F., Vincent, C., Chen, J., Heller, B., Kabler, H., Overcash, J. S., Leylavergne, F., & Dieppois, G. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00250-20 · Cited by 64
Experimental approaches to tracking mobile genetic elements in microbial communities
Saak, C. C., Dinh, C. B., & Dutton, R. J. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa025 · Cited by 62
Shields, R. K., Stellfox, M. E., Kline, E. G., Samanta, P., & Tyne, D. V. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac097 · Cited by 62
Blackwell, G. A., Hamidian, M., & Hall, R. M. (2016) · mSphere · doi:10.1128/msphere.00117-16 · Cited by 61
Khan, A., Tran, T. T., Ríos, R., Hanson, B., Shropshire, W. C., Sun, Z., Díaz, L., Dinh, A. Q., Wanger, A. R., Ostrosky-Zeichner, L. L., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz273 · Cited by 55
Self-citationClones and Clusters of Antimicrobial-ResistantKlebsiellaFrom Southwestern Nigeria
Afolayan, A. O., Oaikhena, A. O., Aboderin, A. O., Olabisi, O. F., Amupitan, A. A., Abiri, O. V., Ogunleye, V. O., Odih, E. E., Adeyemo, A. T., Adeyemo, A. T., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab769 · Cited by 54
Chen, T., Wang, Y., Zhou, Y., Zhou, W., Chi, X., Shen, P., Zheng, B., & Xiao, Y. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.01107-22 · Cited by 53
Bulger, E. M., May, A. K., Robinson, B. R. H., Evans, D. C., Henry, S. M., Green, J. M., Toschlog, E. A., Sperry, J. L., Fagenholz, P. J., Martin, N. D., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004102 · Cited by 52
Lomovskaya, O., Tsivkovski, R., Sun, D., Reddy, R., Totrov, M. M., Hecker, S. J., Griffith, D. C., Loutit, J., & Dudley, M. N. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.697180 · Cited by 52
Watkins, R., Thapaliya, D., Lemonovich, T. L., & Bonomo, R. A. (2023) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkad060 · Cited by 52
Contreras, G., Munita, J. M., Simar, S. R., Luterbach, C., Dinh, A. Q., Rydell, K., Sahasrabhojane, P. V., Ríos, R., Díaz, L., Reyes, K., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab616 · Cited by 51
Self-citationBotelho, J., Tüeffers, L., Fuß, J., Buchholz, F., Utpatel, C., Klockgether, J., Niemann, S., Tümmler, B., & Schulenburg, H. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104532 · Cited by 50
Wegener, H. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3049 · Cited by 48
Matsui, M., Suzuki, M., Suzuki, M., Yatsuyanagi, J., Watahiki, M., Hiraki, Y., Kawano, F., Tsutsui, A., Shibayama, K., & Suzuki, S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02190-17 · Cited by 48
New Perspectives on Antimicrobial Agents: Long-Acting Lipoglycopeptides
Tran, T. T., Villegas, S. G., Aitken, S. L., Butler‐Wu, S. M., Soriano, À., Werth, B. J., & Munita, J. M. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02614-20 · Cited by 46
Silva, K. P. T., Sundar, G., & Khare, A. (2023) · Nature Communications · doi:10.1038/s41467-023-38507-4 · Cited by 44
Brito, B. P., Koong, J., Wozniak, A., Opazo-Capurro, A., To, J., García, P., & Hamidian, M. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02463-22 · Cited by 43
Pirzadian, J., Persoon, M. C., Severin, J. A., Klaassen, C. H. W., de Greeff, S. C., Mennen, M. G., Schoffelen, A. F., Wielders, C. C. H., Witteveen, S., van Santen-Verheuvel, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00205-w · Cited by 42
van Hal, S. J., Willems, R. J. L., Gouliouris, T., Ballard, S. A., Coque, T. M., Hammerum, A. M., Hegstad, K., Pinholt, M., Howden, B. P., Malhotra-Kumar, S., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(21)00236-6 · Cited by 42
Agnello, M., Finkel, S. E., & Wong‐Beringer, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01591 · Cited by 41
The dissemination of multidrug-resistant Enterobacter cloacae throughout the UK and Ireland
Moradigaravand, D., Reuter, S., Martin, V., Peacock, S. J., & Parkhill, J. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.173 · Cited by 37
Boumasmoud, M., Haunreiter, V. D., Schweizer, T. A., Meyer, L., Chakrakodi, B., Schreiber, P. W., Seidl, K., Kühnert, D., Kouyos, R. D., & Zinkernagel, A. S. (2022) · mBio · doi:10.1128/mbio.03771-21 · Cited by 37
DiPippo, A. J., Tverdek, F. P., Tarrand, J. J., Munita, J. M., Tran, T. T., Arias, C. A., Shelburne, S. A., & Aitken, S. L. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.11.004 · Cited by 35
Self-citationWang, G., Yu, F., Lin, H. C., Murugesan, K., Huang, W., Hoss, A. G., Dhand, A., Lee, L. Y., Zhuge, J., Yin, C., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209785 · Cited by 34
Shropshire, W. C., Dinh, A. Q., Earley, M. J., Komarow, L., Panesso, D., Rydell, K., Gomez-Villegas, S. I., Miao, H., Hill, C. B., Chen, L., et al. (2022) · mBio · doi:10.1128/mbio.00497-22 · Cited by 34
Self-citationTao, S., Chen, H., Li, N., Fang, Y., Yao, X., & Liang, W. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s388354 · Cited by 34
Hashimoto, Y., Suzuki, M., Kobayashi, S., Hirahara, Y., Nomura, T., Hirakawa, H., Hirakawa, H., Tanimoto, K., & Tomita, H. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01619-22 · Cited by 34
Rampant Parasexuality Evolves in a Hospital Pathogen during Antibiotic Selection
Beabout, K., Hammerstrom, T. G., Wang, T. T., Bhatty, M., Christie, P. J., Saxer, G., & Shamoo, Y. E. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv133 · Cited by 33
Phylodynamic signatures in the emergence of community-associated MRSA
Steinig, E. J., Aglua, I., Duchêne, S., Meehan, M. T., Yoannes, M., Firth, C., Jaworski, J., Drekore, J., Urakoko, B., Poka, H., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204993119 · Cited by 25
Lee, R. A., Goldman, J. D., Haidar, G., Lewis, J. D., Arif, S., Hand, J. M., Hoz, R. M. L., Pouch, S. M., Holaday, E., Clauss, H. E., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab659 · Cited by 24
Li, L., Higgs, C. K., Turner, A. M., Nong, Y., Gorrie, C. L., Sherry, N. L., Dyet, K. H., Seemann, T., Williamson, D. A., Stinear, T. P., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.749935 · Cited by 23
Boumghar-Bourtchaï, L., Dhalluin, A., Malbruny, B., Galopin, S., & Leclercq, R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01633-08 · Cited by 21
Cheikh, H. B., Domingues, S., Silveira, E., Kadri, Y., Rosário, N., Mastouri, M., & Silva, G. (2018) · 3 Biotech · doi:10.1007/s13205-018-1310-3 · Cited by 18
In vitro activity of eravacycline and mechanisms of resistance in enterococci
Boukthir, S., Dejoies, L., Zouari, A., Collet, A., Potrel, S., Auger, G., & Cattoir, V. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106215 · Cited by 18
Cited by
Antimicrobial resistance: a concise update
Ho, C. S., Wong, C. T. H., Aung, T. T., Lakshminarayanan, R., Mehta, J. S., Rauz, S., McNally, A., Kintses, B., Peacock, S. J., de la Fuente-Nunez, C., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.07.010 · Cited by 634
A new framework for Subti Wiki, the database for the model organism Bacillus subtilis
Elfmann, C., Dumann, V., van den Berg, T., & Stülke, J. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae957 · Cited by 47
Clonal Candida auris and ESKAPE pathogens on the skin of residents of nursing homes
Proctor, D. M., Sansom, S. E., Deming, C., Conlan, S., Blaustein, R. A., Atkins, T. K., Program, N. C. S., Mullikin, J., Thomas, J., Young, A., et al. (2025) · Nature · doi:10.1038/s41586-025-08608-9 · Cited by 37
Structural insights into Cir-mediated killing by the antimicrobial protein Microcin V
Maurakis, S. A., O’Donnell, A. C., Botos, I., Ghirlando, R., Davies, B. W., & Buchanan, S. K. (2025) · Communications Biology · doi:10.1038/s42003-025-08846-7 · Cited by 3
Stuart, W. S., Jenkins, C. H., Ireland, P. M., Isupov, M. N., Norville, I. H., & Harmer, N. J. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108517 · Cited by 1
Metadata
- Authors
- Miller, W. R., & Arias, C. A.
- Venue
- Nature Reviews Microbiology
- Published
- 2024-06-03
- Volume
- 22
- Issue
- 10
- Pages
- 598-616
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W4399302728
- Cited by
- 862
- References
- 205
- FWCI
- 39.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.